| Biotechnology feed | All feeds
Year-end Report January??December 2009 Key events during the year?
Net revenues totaled MSEK 236.1 (233.3)?
The loss after tax was MSEK 98.1 (loss: 103.1)?
The loss per share amounted to a loss of SEK 4.32 (loss: 4.77)?
Cash and... Therapeutics Daily: Feb 18 2010 2:19AM Matching: edluar Find similar documents
The loss after tax was MSEK 98.1 (loss: 103.1).
The loss per share amounted to a loss of SEK 4.32 (loss: 4.77).
Cash and cash equivalents at year-end totaled MSEK 87.4 (188.2).
Abstral was launched in UK, Germany... News-Medical.Net: Feb 17 2010 10:14AM Matching: edluar Find similar documents
Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.
All rights reserved. All other trademarks recognized. Copyright 1997-2009 - BioPortfolio Limited.
